Metrics
- Price
- $27.35
- Market Cap $M
- 60
- Rel Volume
- 0.48
- Vol Up 2W
- 55.60%
- Vol Trend 2W
- +108.90%
- 1D
- +1.51%
- 1W
- +3.98%
- 1M
- +58.25%
- 1M Slope
- +73.28%
- 6M Range
- 112.81%
- Score
- 77.6
- Sharp
- -14.9
Volume
Profile
Apollomics is a clinical-stage biotechnology company developing cancer therapies aimed at unmet medical needs across solid tumors and hematologic malignancies.
Biotech
Pharmaceuticals